Form 4 Filing by MATA NATHAN L.

On April 24, 2026, Nathan L. Mata, Chief Scientific Officer of BELITE BIO, INC, reported the disposition of 1160 shares of American depositary shares. These transactions were executed under a Rule 10b5-1 trading plan. The shares were sold at prices ranging from $157.81 to $162.53. The total number of shares disposed of is 1160, resulting in a post-transaction ownership of 8666 shares. The weighted average price for these sales varied depending on the tranche, with details provided in the footnotes regarding specific price ranges and undertakings to provide further information upon request.